US · guidance

CMS SOM App. J, Tag W362

W361, W363, W364,

activein force · 2026-07-22 – presentas-observed

A pharmacist with input W365, W366, W367,

from the interdisciplinary W368, W369, W370,

team must review the drug W371, W372, W373,

regimen of each client at W374, W375, W376

least quarterly

42 CFR 483.460(l)(2)

Provenance

Source: cms.gov
Retrieved: 2026-07-22
Edition: som-2026-07-22
Content hash: 2274ff59533c6a8712d44c657e43118a9f705268d1b1bf057f8f842f7910d3ca

View the official source →

The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.

Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.

Coverage · API docs